Abstract:Although sleep is a ubiquitous behavior in animal species with well-developed central nervous systems, many aspects in the neurobiology of sleep remain mysterious. Our discovery of orexin, a hypothalamic neuropeptide involved in the maintenance of wakefulness, has triggered an intensive research examining the exact role of the orexinergic and other neural pathways in the regulation of sleep/wakefulness. The orexin receptor antagonist suvorexant, which specifically block the endogenous waking system, has been approved as a new drug to treat insomnia. Also, since the sleep disorder narcolepsy-cataplexy is caused by orexin deficiency, orexin receptor agonists are expected to provide mechanistic therapy for narcolepsy; they will likely be also useful for treating excessive sleepiness due to other etiologies.Despite the fact that the executive neurocircuitry and neurochemistry for sleep/wake switching has been increasingly revealed in recent years, the mechanism for homeostatic regulation of sleep, as well as the neural substrate for "sleepiness" (sleep need), remains unknown. To crack open this black box, we have initiated a large-scale forward genetic screen of sleep/wake phenotype in mice based on true somnographic (EEG/EMG) measurements. We have so far screened >8,000 heterozygous ENU-mutagenized founders and established a number of pedigrees exhibiting heritable and specific sleep/wake abnormalities. By combining linkage analysis and the next-generation whole exome sequencing, we have molecularly identified and verified the causal mutation in several of these pedigrees. Biochemical and neurophysiological analyses of these mutations are underway. Since these dominant mutations cause strong phenotypic traits, we expect that the mutated genes will provide new insights into the elusive pathway regulating sleep/wakefulness. Indeed, through a systematic cross-comparison of the Sleepy mutants and sleep-deprived mice, we have recently found that the cumulative phosphorylation state of a specific set of mostly synaptic proteins may be the molecular substrate of sleep need.

Research progress of narcolepsy

Advances in narcolepsy

From past to future: 50 years of pharmacological interventions to treat narcolepsy

Narcolepsy, orexins and respiratory regulation

Recent insights into the pathophysiology of narcolepsy type 1

Respiratory Regulation in Narcolepsy

Toward the Mysteries of Sleep

Significance of determining plasma orexin levels and analysis of related factors for the diagnosis of patients with narcolepsy

Neural Circuits for Sleep-Wake Regulation

Orexin Receptor Antagonists: a Promising Approach to the Treatment of Insomnia

Sleepiness That Cannot Be Overcome: Narcolepsy And Cataplexy

[Clinical and sleep EEG monitoring characteristics and long-term follow-up study on narcolepsy].

Pharmacology of sleep in China:research and prospect

Hits and misses with animal models of narcolepsy and the implications for drug discovery

Bibliometric analysis of orexin: A promising neuropeptide

Impaired cognition in narcolepsy: clinical and neurobiological perspectives

Orexin Receptor Antagonists As Emerging Treatments for Psychiatric Disorders

Clinical features and mechanisms of neck myoclonus in narcolepsy

Serum metabolomics study of narcolepsy type 1 based on ultra-performance liquid chromatography–tandem mass spectrometry

[Value of Cerebral Spinal Fluid Measurement of Hypocretin-1 in the Diagnosis of Chinese Patients with Narcolepsy].

Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation